Matches in Wikidata for { <http://www.wikidata.org/entity/Q45892886> ?p ?o ?g. }
- Q45892886 description "2015 nî lūn-bûn" @default.
- Q45892886 description "2015 թվականի նոյեմբերի 4-ին հրատարակված գիտական հոդված" @default.
- Q45892886 description "2015 നവംബര് 4 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q45892886 description "2015年の論文" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年学术文章" @default.
- Q45892886 description "2015年學術文章" @default.
- Q45892886 description "2015年學術文章" @default.
- Q45892886 description "2015年學術文章" @default.
- Q45892886 description "2015年學術文章" @default.
- Q45892886 description "2015年學術文章" @default.
- Q45892886 description "2015년 논문" @default.
- Q45892886 description "article científic" @default.
- Q45892886 description "article scientific" @default.
- Q45892886 description "article scientifique" @default.
- Q45892886 description "articol științific" @default.
- Q45892886 description "articolo scientifico" @default.
- Q45892886 description "artigo científico" @default.
- Q45892886 description "artigo científico" @default.
- Q45892886 description "artigo científico" @default.
- Q45892886 description "artikel ilmiah" @default.
- Q45892886 description "artikull shkencor" @default.
- Q45892886 description "artikulong pang-agham" @default.
- Q45892886 description "artykuł naukowy" @default.
- Q45892886 description "artículo científico publicado en 2015" @default.
- Q45892886 description "artículu científicu" @default.
- Q45892886 description "bilimsel makale" @default.
- Q45892886 description "bài báo khoa học" @default.
- Q45892886 description "naučni članak" @default.
- Q45892886 description "scienca artikolo" @default.
- Q45892886 description "scientific article published on 4 November 2015" @default.
- Q45892886 description "scientific article published on 4 November 2015" @default.
- Q45892886 description "scientific article published on 4 November 2015" @default.
- Q45892886 description "teaduslik artikkel" @default.
- Q45892886 description "tieteellinen artikkeli" @default.
- Q45892886 description "tudományos cikk" @default.
- Q45892886 description "vedecký článok" @default.
- Q45892886 description "vetenskaplig artikel" @default.
- Q45892886 description "videnskabelig artikel" @default.
- Q45892886 description "vitenskapelig artikkel" @default.
- Q45892886 description "vitskapeleg artikkel" @default.
- Q45892886 description "vědecký článek" @default.
- Q45892886 description "wetenschappelijk artikel" @default.
- Q45892886 description "wissenschaftlicher Artikel" @default.
- Q45892886 description "επιστημονικό άρθρο" @default.
- Q45892886 description "мақолаи илмӣ" @default.
- Q45892886 description "наукова стаття, опублікована в листопаді 2015" @default.
- Q45892886 description "научна статия" @default.
- Q45892886 description "научная статья" @default.
- Q45892886 description "научни чланак" @default.
- Q45892886 description "научни чланак" @default.
- Q45892886 description "מאמר מדעי" @default.
- Q45892886 description "مقالة علمية نشرت في 4 نوفمبر 2015" @default.
- Q45892886 description "৪ নভেম্বর ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45892886 description "บทความทางวิทยาศาสตร์" @default.
- Q45892886 description "სამეცნიერო სტატია" @default.
- Q45892886 name "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 name "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 type Item @default.
- Q45892886 label "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 label "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 prefLabel "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 prefLabel "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR." @default.
- Q45892886 P1433 Q45892886-C2749750-14CD-48D8-B70D-0511F7D1AD1B @default.
- Q45892886 P1476 Q45892886-EB910FC4-0991-40CA-81F4-6D9D82AD4740 @default.
- Q45892886 P2093 Q45892886-2CF6B2DD-B384-44C0-944D-B4D7DB614677 @default.
- Q45892886 P2093 Q45892886-4169530C-1575-4877-9057-D0E8B99FA439 @default.
- Q45892886 P2093 Q45892886-63873494-DC2A-49F8-8E7B-88CBE4D3DF9F @default.
- Q45892886 P2093 Q45892886-6EB7C756-380C-40EA-8E8D-E20D0B77C844 @default.
- Q45892886 P2093 Q45892886-877FD976-EFEE-4C4F-BBC6-C41E3770339F @default.
- Q45892886 P2093 Q45892886-89D37695-9593-48D0-86C4-06046EC2480B @default.
- Q45892886 P2093 Q45892886-96632425-5DF9-4DC1-8361-618512063186 @default.
- Q45892886 P2093 Q45892886-FEADB4F7-5CE3-4EFC-90BE-D12F791D4BD8 @default.
- Q45892886 P2888 Q45892886-1E90D9ED-19C0-4372-BB47-DB6BC88F35BB @default.
- Q45892886 P304 Q45892886-BD50322E-2304-4D78-B029-DCE63EFD7ED1 @default.
- Q45892886 P31 Q45892886-83B6EFA6-D6B0-4949-9DC5-8EBEF5C825D5 @default.
- Q45892886 P356 Q45892886-389FAE66-15CD-438D-AF69-2A429545E4EF @default.
- Q45892886 P433 Q45892886-E41578B7-DB19-4A3D-9A12-4003BBEA7E4D @default.
- Q45892886 P478 Q45892886-3C6C38F3-057F-40DE-AA5C-930909DE6007 @default.
- Q45892886 P50 Q45892886-EEC46390-7347-4B3D-B070-2F12D7FF8C4F @default.
- Q45892886 P577 Q45892886-6F02FD6B-13C6-41C1-8206-4FDCD917ABE1 @default.
- Q45892886 P6179 Q45892886-437A8F49-8162-4221-93E3-AFE5B49C7573 @default.
- Q45892886 P921 Q45892886-1DFBF771-3905-45FE-8E63-0306E4054C12 @default.
- Q45892886 P932 Q45892886-18CDCCEB-7E20-4B4E-8CCB-91F901B74F50 @default.
- Q45892886 P356 2051-1426-3-S2-P152 @default.
- Q45892886 P1433 Q27725163 @default.
- Q45892886 P1476 "Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR" @default.
- Q45892886 P2093 "Anthony Jarkowski" @default.
- Q45892886 P2093 "Christophe Le Tourneau" @default.
- Q45892886 P2093 "Giovanni Melillo" @default.
- Q45892886 P2093 "Jerome Fayette" @default.
- Q45892886 P2093 "Jill Gilbert" @default.
- Q45892886 P2093 "Lilian L Siu" @default.
- Q45892886 P2093 "Trishna Goswami" @default.
- Q45892886 P2093 "Ugochi Emeribe" @default.
- Q45892886 P2888 2051-1426-3-s2-p152 @default.